论文部分内容阅读
目的:讨论在临床足月引产中应用小剂量米索前列醇结合缩宫素的效果以及安全性。方法:选取我院2012年7月-2014年6月收治治疗的80例足月引产孕妇,随机将其分成观察组与对照组,其中对照组患者选择缩宫素,而观察组则在对照组治疗方法的前提下,选择小剂量米索前列醇。结果:两组患者经过治疗后,对照组孕妇的引产总有效率为65.0%,而观察组孕妇的引产总有效率为92.5%,观察组患者的引产总有效率明显的高于对照组,其存在着一定的差异,具备统计学意义(P<0.05)。结论:对于足月引产孕妇来说,应用小剂量米索前列醇结合缩宫素具备着显著的临床效果,其可以有效的对患者宫缩进行诱发,并使产程得到缩短。
PURPOSE: To discuss the efficacy and safety of low-dose misoprostol in combination with oxytocin in clinical term labor. Methods: Eighty pregnant women with term induced abortion were selected from July 2012 to June 2014 in our hospital. Patients in the control group were randomly divided into observation group and control group. Oxytocin was given to the control group and control group Under the premise of treatment, choose a small dose of misoprostol. Results: After treatment, the total effective rate of labor induction in pregnant women in the control group was 65.0%, while the total effective rate in induced labor in the observation group was 92.5%. The total effective rate of labor induction in the observation group was significantly higher than that of the control group There are some differences, with statistical significance (P <0.05). Conclusion: For full-term pregnant women, the use of low-dose misoprostol combined with oxytocin has a significant clinical effect, which can effectively induce contractions in patients and reduce the birth process.